Loading...
XSHG
600829
Market cap681mUSD
Jul 10, Last price  
8.16CNY
1D
2.38%
1Q
-22.36%
Jan 2017
-46.60%
Name

HPGC Renmintongtai Pharmaceutical Corp

Chart & Performance

D1W1MN
XSHG:600829 chart
P/E
35.35
P/S
0.46
EPS
0.23
Div Yield, %
1.81%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
5.33%
Revenues
10.38b
+3.29%
2,064,447,6972,268,208,0722,594,344,1272,638,253,1813,005,088,5953,605,738,9034,068,385,2913,177,004,8529,010,672,0338,909,315,3379,005,558,9838,008,880,9517,055,220,8848,353,884,4518,005,259,6889,315,235,6129,641,093,05410,389,980,12310,048,279,39210,378,712,197
Net income
134m
-37.24%
218,245,193268,085,492269,281,487278,786,373333,817,995398,595,494363,973,3116,462,060187,410,991138,916,256224,509,932254,196,038257,859,440267,334,547145,263,632277,296,180264,478,406292,161,817213,272,266133,839,929
CFO
300m
+159.86%
191,131,434191,103,6380447,824,979162,986,4910221,573,4020392,578,769333,987,60546,010,726139,074,593366,451,822000307,327,849332,985,565115,436,166299,975,689
Dividend
Jul 25, 20240.144 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise actively involved in the wholesale and retail distribution of diverse medicinal products across China and internationally. Its extensive product portfolio encompasses traditional Chinese medicines, herbal remedies, chemical preparations, antibiotics, biologics, biochemical drugs, medical equipment, and health-related items. The company also extends its operations to include logistics services, specifically warehousing and distribution. Additionally, it offers comprehensive hospital services covering medical treatment, scientific research, disease prevention, health promotion, rehabilitation, blood purification, and renal disease management. Through its e-commerce platform, HPGC Renmintongtai markets a broad selection of items, including Chinese and Western pharmaceuticals, traditional Chinese herbs, nutritional supplements, medical devices, cosmetics, and everyday necessities. The company maintains a significant retail presence with 319 chain stores located throughout Heilongjiang Province. Established in 1950 and headquartered in Harbin, China, HPGC Renmintongtai Pharmaceutical Corporation operates as a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
IPO date
Feb 24, 1994
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT